Diabetic hypertensive control and treatment: a descriptive report from the audit diabetes control and management (adcm) registry
- PMID: 25606205
- PMCID: PMC4170408
Diabetic hypertensive control and treatment: a descriptive report from the audit diabetes control and management (adcm) registry
Abstract
Introduction: Hypertension is a common co-morbidity in diabetes mellitus (DM) that may lead to serious complications if not adequately controlled.
Method: This is a descriptive study based on data from the Audit of Diabetes Control and Management (ADCM) registry. This audit assessed the treatment and standard of control of hypertension in diabetic patients aged 18 years and above. Data were analysed using STATA version 9.
Results: From a total of 20 646 cases, about two third of them, 13 417 (65%) were reported to have hypertension. 19 484 (94.4%) had their blood pressure (BP) recorded and out of these, 11 414 (58.5%) were found to have BP >130/80 mmHg. 13 601 cases (65.9%) of the total sample were on antihypertensive drugs. 64.1% of those on antihypertensive drugs were prescribed angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers. 14.2% were on more than two types of antihypertensive drugs. Older patients and those with longer duration of DM were less likely to achieve the target BP of ≤130/80. In general, about 40% of diabetic cases registered in the ADCM project had their hypertension well controlled.
Keywords: Diabetes mellitus; antihypertensives; hypertension; primary care; registries.
Figures
References
-
- Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992;19((5)):403–18. - PubMed
-
- Williams B. Insulin resistance; the shape of things to come. Lancet. 1994;344((8921)):521–4. - PubMed
-
- Williams G. In: Pickup J, Williams G, editors. London: Blackwell Scientific Publications; 1991. Hypertension in diabetes; pp. 719–32. Textbook of diabetes.
-
- DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14((3)):173–94. - PubMed
-
- Nishimura R, LaPorte RE, Dorman JS. et al. Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes Care. 2001;24((5)):823–7. - PubMed